<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110987">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01952665</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-41</org_study_id>
    <nct_id>NCT01952665</nct_id>
  </id_info>
  <brief_title>A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear</brief_title>
  <official_title>A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over
      1 Month of Daily Wear
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two-month, single masked, randomized, bilateral, crossover, 1-month of daily wear in each
      study lens.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Comfort, handling and dryness scores are measured using a Visual Analog Scale from 0 -10</measure>
    <time_frame>Visits: V1 (Baseline), V2 (2 weeks), V3 (4 weeks), V4 (6-weeks), V5 (8-weeks)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subjective Patient Ratings: Comfort, handling and dryness scores are measured using a Visual Analog Scale from 0 -10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ocular response assessed with the slit lamp using a Visual Analog Scale from 0 - 4</measure>
    <time_frame>Visits: V1 (Baseline), V2 (2 weeks), V3 (4 weeks), V4 (6-weeks), V5 (8-weeks)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Objective Practitioner Measurements: Ocular response assessed with the slit lamp using a Visual Analog Scale from 0 - 4</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>comfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily wear soft contact lens comfilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lotrafilcon B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily wear soft contact lens lotrafilcon B</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comfilcon A</intervention_name>
    <description>Each subject randomized to wear the test lens (comfilcon A) or the control lens (lotrafilcon B) for one month of daily wear before repeating schedule for the second pair without a washout period.</description>
    <arm_group_label>lotrafilcon B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lotrafilcon B</intervention_name>
    <description>Each subject randomized to wear the test lens (comfilcon A) or the control lens (lotrafilcon B) for one month of daily wear before repeating schedule for the second pair without a washout period.</description>
    <arm_group_label>comfilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Is between 18 and 40 years of age (inclusive)

          -  Have the use of a mobile phone to send and receive text messages throughout the day
             for the duration of the study

          -  Has had a self-reported visual exam in the last two years

          -  Is an adapted soft CL wearer

          -  Has a CL spherical prescription between - 1.00 and - 9.00 (inclusive)

          -  Has less than 0.75D spectacle cylinder in each eye

          -  Is correctable to a visual acuity of 20/25 or better in both eyes

          -  Has clear corneas and no active ocular disease

          -  Has read, understood and signed the information consent letter

          -  Is willing to comply with the wear schedule (at least 40 hrs per week)

          -  Is willing to comply with the visit schedule

        Exclusion Criteria:

          -  Has never worn contact lenses before

          -  Currently wears rigid gas permeable contact lenses

          -  Has a history of not achieving comfortable CL wear (5 days per week; &gt; 8 hours/day)

          -  Has a contact lens prescription outside the range of - 1.00 to -9.00D

          -  Has a spectacle cylinder greater than -0.50D of cylinder in either eye

          -  Has best corrected spectacle distance vision worse then 20/25 in either eye

          -  Has any systemic disease affecting ocular health

          -  Is using any systemic or topical medications that will affect ocular health

          -  Has any ocular pathology or severe insufficiency of lacrimal secretion

          -  Has persistent, clinically significant corneal or conjunctival staining

          -  Has active neovascularization or any central corneal scars

          -  Is aphakic

          -  Is presbyopic

          -  Has undergone corneal refractive surgery

          -  Is participating in any other type of eye related clinical or research study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald Siegel, OD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CooperVision, US</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Family Eye Care Center</name>
      <address>
        <city>Campbell</city>
        <state>California</state>
        <zip>95008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golden Optometric Group</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drs. Quinn, Foster, &amp;Associates</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>45701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Davis EyeCare Associates</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kannarr Eye Care LLC</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complete Eye Care of Medina</name>
      <address>
        <city>Medina</city>
        <state>Minnesota</state>
        <zip>55340</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>September 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
